Pranzatelli, Michael R <br/><br/>
Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus.  [electronic resource] 

 -  Pediatric blood & cancer  Jun 2012 
 - 988-91 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.23187  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Drug Hypersensitivity--etiology<br/>Ganglioneuroblastoma--complications<br/>Humans<br/>Infant<br/>Male<br/>Opsoclonus-Myoclonus Syndrome--drug therapy<br/>Rituximab<br/>Spinal Cord Neoplasms--complications